BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23864250)

  • 1. A comparison of measured and estimated glomerular filtration rate for carboplatin dose calculation in stage I testicular seminoma.
    Quinton A; Lewis P; Ali P; Morgan C; Bertelli G
    Med Oncol; 2013; 30(3):661. PubMed ID: 23864250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort.
    Cathomas R; Klingbiel D; Geldart TR; Mead GM; Ellis S; Wheater M; Simmonds P; Nagaraj N; von Moos R; Fehr M
    Ann Oncol; 2014 Aug; 25(8):1591-7. PubMed ID: 24669017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula.
    Nagao S; Fujiwara K; Imafuku N; Kagawa R; Kozuka Y; Oda T; Maehata K; Ishikawa H; Koike H; Aotani E; Kohno I
    Gynecol Oncol; 2005 Nov; 99(2):327-33. PubMed ID: 16005943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma.
    Shepherd ST; Gillen G; Morrison P; Forte C; Macpherson IR; White JD; Mark PB
    Eur J Cancer; 2014 Mar; 50(5):944-52. PubMed ID: 24445148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of glomerular filtration rate estimation by Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patients.
    Ainsworth NL; Marshall A; Hatcher H; Whitehead L; Whitfield GA; Earl HM
    Ann Oncol; 2012 Jul; 23(7):1845-53. PubMed ID: 22104575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients.
    Marx GM; Blake GM; Galani E; Steer CB; Harper SE; Adamson KL; Bailey DL; Harper PG
    Ann Oncol; 2004 Feb; 15(2):291-5. PubMed ID: 14760124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies.
    de Lemos ML; Hsieh T; Hamata L; Levin A; Swenerton K; Djurdjev O; Vu T; Hu F; Conklin J; Malfair Taylor SC
    Gynecol Oncol; 2006 Dec; 103(3):1063-9. PubMed ID: 16875719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae.
    Okamoto H; Nagatomo A; Kunitoh H; Kunikane H; Watanabe K
    Cancer Chemother Pharmacol; 1998; 42(4):307-12. PubMed ID: 9744776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flat dosing of carboplatin is justified in adult patients with normal renal function.
    Ekhart C; de Jonge ME; Huitema AD; Schellens JH; Rodenhuis S; Beijnen JH
    Clin Cancer Res; 2006 Nov; 12(21):6502-8. PubMed ID: 17085665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey.
    Diminutto A; Basso U; Maruzzo M; Morelli F; De Giorgi U; Perin A; Fraccon AP; Lo Re G; Rizzi A; Sava T; Fornarini G; Valcamonico F; Zustovich F; Massari F; Zanardi E; Roma A; Zattoni F; Zagonel V
    Clin Genitourin Cancer; 2016 Apr; 14(2):e161-9. PubMed ID: 26775721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing.
    Donahue A; McCune JS; Faucette S; Gillenwater HH; Kowalski RJ; Socinski MA; Lindley C
    Cancer Chemother Pharmacol; 2001 May; 47(5):373-9. PubMed ID: 11391850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboplatin dosing in the era of IDMS-creatinine; the Cockroft-Gault formula no longer provides a sufficiently accurate estimate of glomerular filtration rate for routine use in clinical care.
    McLean L; Whittle JR; Graham J; Ismail H; Lichtenstein M; Hicks RJ; McNally O; Herschtal A; Rosenthal M; Rischin D; Hamilton A
    Gynecol Oncol; 2020 Jun; 157(3):793-798. PubMed ID: 32220419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of AUC7 adjuvant carboplatin in patients with stage I seminoma: systematic review of the literature.
    Siracusano S; Diminutto A; Porcaro AB; Cerruto MA; Artibani W
    Tumori; 2018; 104(2):83-87. PubMed ID: 27791233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboplatin dosing: gender bias and inaccurate estimates of glomerular filtration rate.
    Dooley MJ; Poole SG; Rischin D; Webster LK
    Eur J Cancer; 2002 Jan; 38(1):44-51. PubMed ID: 11750838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers.
    Samani A; Bennett R; Eremeishvili K; Kalofonou F; Whear S; Montes A; Kristeleit R; Krell J; McNeish I; Ghosh S; Tookman L
    ESMO Open; 2022 Apr; 7(2):100401. PubMed ID: 35227967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance.
    White-Koning M; Paludetto MN; Le Louedec F; Gladieff L; Chevreau C; Chatelut E; Puisset F
    Cancer Chemother Pharmacol; 2020 Mar; 85(3):585-592. PubMed ID: 31915969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboplatin Dosing Accuracy by Estimation of Glomerular Filtration versus Creatinuria in Cancer Patients.
    Graciano Vera N; Pino Villarreal L; Ureña Vargas J
    Chemotherapy; 2018; 63(3):137-142. PubMed ID: 29768260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of bedside renal function estimates and measured glomerular filtration rate (Tc99mDTPA clearance) in cancer patients.
    Poole SG; Dooley MJ; Rischin D
    Ann Oncol; 2002 Jun; 13(6):949-55. PubMed ID: 12123341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of carboplatin dosing in patients with a glomerular filtration rate greater than 125 mL/min: To cap or not to cap? A retrospective analysis and review.
    Morrow A; Garland C; Yang F; De Luna M; Herrington JD
    J Oncol Pharm Pract; 2019 Oct; 25(7):1651-1657. PubMed ID: 30336729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of glomerular filtration rate in cancer patients.
    Wright JG; Boddy AV; Highley M; Fenwick J; McGill A; Calvert AH
    Br J Cancer; 2001 Feb; 84(4):452-9. PubMed ID: 11207037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.